Efficacy and Safety of SPD465 in Adults With Moderately Symptomatic ADHD.
Status:
Completed
Trial end date:
2005-11-04
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and effectiveness of SPD465 compared to
placebo (a capsule with no medication in it) in the treatment of ADHD. The study will also
look at how SPD465 affects the participants sleep and how they perceive their quality of
life.